Dr. Patrick Bryan Mazi, MD

Dr. Mazi practices at Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health.

Dr. Mazi's NPI, 1063875995, was assigned on March 29, 2016. Dr. Mazi holds Missouri license 2020027277.

Dr. Mazi's primary practice is Barnes-Jewish Hospital, at One Barnes-Jewish Hospital Plaza, Saint Louis, MO 63110 in St. Louis City. The practice phone is (314) 747-3000. Dr. Mazi also practices at Barnes-Jewish Hospital, 1 Barnes Jewish Hospital Plz, Saint Louis, MO 63110.

Dr. Mazi's primary practice is Barnes-Jewish Hospital in Saint Louis, Missouri, part of BJC Health. The medical group on file is WashU Medicine Psychiatry. Dmand AI also links Dr. Mazi to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Mazi practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Mazi's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Mazi is licensed in Missouri.

CMS data shows 273 Medicare services from Dr. Mazi across 7 procedure codes in 2024, for 151 Medicare patients. Medicare paid $33,817 for them.

CMS counts 151 Medicare patients who saw Dr. Mazi in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 24% are also on Medicaid. Their average risk score is 4.02, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Mazi's median patient age at 68, with 54% women.

In 2024, Dr. Mazi wrote 184 Medicare Part D claims for 40 patients. 87% of them were for generic drugs. CMS names the drug for 146 of them, across 8 drugs with 11 or more claims each, at $140,664 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Mazi for performance year 2024, reported as part of a group. Dr. Mazi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Mazi as offering telehealth.

Dmand AI links 14 papers to Dr. Mazi, published from 2021 to 2025. 2022 was the busiest year, with 3. The most frequent topics are Antifungal Agents, Histoplasmosis and Invasive Fungal Infections. Dr. Mazi has published most often in Open Forum Infect Dis. Dr. Mazi's most frequent co-authors are Andrej Spec, MD, William G. Powderly, MD and Sandra L. R. Arnold, MD.

CMS Open Payments shows 4 general payments to Dr. Mazi from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Melinta Therapeutics, Inc. paid the most, $172.